Suchergebnisse - "Sakamoto, Keita"

PubPharm (114)

101

Clinicopathological and Prognostic Significance of Preoperative Serum Zinc Status in Patients with Hepatocellular Carcinoma After Initial Hepatectomy

enthalten in: Annals of surgical oncology | 2014

von Imai, K. | Beppu, T. | Yamao, T. | +10

102

Clinicopathological and Prognostic Significance of Preoperative Serum Zinc Status in Patients with Hepatocellular Carcinoma After Initial Hepatectomy

enthalten in: Annals of surgical oncology | 2014

von Imai, K. | Beppu, T. | Yamao, T. | +10

103

Clinicopathological and Prognostic Significance of Preoperative Serum Zinc Status in Patients with Hepatocellular Carcinoma After Initial Hepatectomy

enthalten in: Annals of surgical oncology | 2014

von Imai, K. | Beppu, T. | Yamao, T. | +10

104

Epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A inhibits the growth of cholangiocarcinoma cells

enthalten in: Oncology reports | 2014

von Nakagawa, S. | Sakamoto, Y. | Okabe, H. | +9

105

Epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A inhibits the growth of cholangiocarcinoma cells

enthalten in: Oncology reports | 2014

von Nakagawa, S. | Sakamoto, Y. | Okabe, H. | +9

106

Enhancer of zeste homolog 2 (EZH2) promotes progression of cholangiocarcinoma cells by regulating cell cycle and apoptosis

enthalten in: Annals of surgical oncology | 2013

von Nakagawa, S. | Okabe, H. | Sakamoto, Y. | +12

107

The modified Glasgow Prognostic Score (mGPS) is a good predictor of indication for palliative bypass surgery in patients with unresectable pancreatic and biliary cancers

enthalten in: International journal of clinical oncology | 2013

von Ikuta, Y. | Takamori, H. | Sakamoto, Y. | +12

108

The modified Glasgow Prognostic Score (mGPS) is a good predictor of indication for palliative bypass surgery in patients with unresectable pancreatic and biliary cancers

enthalten in: International journal of clinical oncology | 2013

von Ikuta, Y. | Takamori, H. | Sakamoto, Y. | +12

109

The modified Glasgow Prognostic Score (mGPS) is a good predictor of indication for palliative bypass surgery in patients with unresectable pancreatic and biliary cancers

enthalten in: International journal of clinical oncology | 2013

von Ikuta, Y. | Takamori, H. | Sakamoto, Y. | +12

110

Enhancer of Zeste Homolog 2 (EZH2) Promotes Progression of Cholangiocarcinoma Cells by Regulating Cell Cycle and Apoptosis

enthalten in: Annals of surgical oncology | 2013

von Nakagawa, S. | Okabe, H. | Sakamoto, Y. | +12

[1]
« Vorheriger
2
3
4
5
6
7
8
9
10
11
12
Nächster »
[12]